N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-]

N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] 価格

N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] 化学特性,用途語,生産方法

• 使用

  Virginiamycin complex is defined as a mixture of 75% ostreogrycin A (virginamycin M1) and 25% virginiamycin S1, together with the less abundant S analogues. As the two major components have quite different solubilities, these proportions are not readily achieved or used. BioAustralis has isolated and re-combined the individual components to provide the defined components of virginiamycin complex. The composition of the complex is important as Virginiamycin S1 acts a synergist, binding to the conformational change of the peptidyl transferase centre of the 50S ribosome induced by ostreogrycin A.

• 接触アレルゲン

  Like the other streptogramin, pristinamycin, virginiamycin is made of two subunits, virginiamycin S1 and virginiamycin M1. Dermatitis was quite common in people using the formerly available topical virginiamycin. Occupational dermatitis was observed in the pharmaceutical industry, in breeders, and in a surgeon who used topical virginiamycin on postoperative wounds (personal observation).

N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] 生産企業

Global(53)Suppliers

23152-29-6, N-[(3-ヒドロキシ-2-ピリジル)カルボニル]シクロ[L-Thr*-D-Abu-L-Pro-N-メチル-L-Phe-4-オキソ-L-Pip-L-フェニルGly-] キーワード